{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T16:40:14Z","timestamp":1682786414516},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.1007\/bf00309386","type":"journal-article","created":{"date-parts":[[2004,10,19]],"date-time":"2004-10-19T16:26:18Z","timestamp":1098203178000},"page":"55-58","source":"Crossref","is-referenced-by-count":1,"title":["Serum-soluble interleukin-2 receptor levels before and after surgical treatment for graves' disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Saburo","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Kuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Murai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuima","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Satomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1126\/science.3131876","volume":"240","author":"KA Smith","year":"1988","unstructured":"Smith KA (1988) Interleukin-2, inception, impact and implications. Science 240:1169","journal-title":"Science"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","volume":"135","author":"LA Rubin","year":"1985","unstructured":"Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL (1985) Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3172?3177","journal-title":"J Immunol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.141.8.2612","volume":"141","author":"JA Symons","year":"1988","unstructured":"Symons JA, Wod NC, Di Giovine FS, Duff GW (1988) Soluble IL-2 receptor in rheumatoid arthritis: correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol 141:2612?2618","journal-title":"J Immunol"},{"key":"CR4","first-page":"457","volume":"116","author":"K Yamaguchi","year":"1990","unstructured":"Yamaguchi K, Nishimura Y, Kiyokawa T, Matsuzaki H, Ishii T, Kubota K, Kawahara M, Furuse K, Yoshinaga T, Kinuwaki E, Takatsuki K (1990) Elevated serum levels of soluble interleukin 2 receptors in small cell lung carcinoma. J Lab Clin Med 116:457?461","journal-title":"J Lab Clin Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V71.4.1135.1135","volume":"71","author":"CH Pui","year":"1988","unstructured":"Pui CH, Ip SH, Iflah S, Behm FG, Grose BH, Dodge RK, Crist WM, Furman WL, Murphy SB, Rivera GK (1988) Serum Interleukin 2 receptor levels in childhood acute lymphoblastic leukemia. Blood 71:1135?1137","journal-title":"Blood"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.4049\/jimmunol.142.12.4248","volume":"142","author":"M Honda","year":"1989","unstructured":"Honda M, Kitamura K, Matsuda K, Yokota Y, Yamamoto N, Mitsuyasu R, Chermann JC, Tokunaga T (1989) Soluble IL-2 receptor in AIDS. J Immunol 142:4248?4255","journal-title":"J Immunol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000181868","volume":"35","author":"G Weryha","year":"1991","unstructured":"Weryha G, Gobert B, Leclere J, Bene MC, Faure G, Hartemann P (1991) Dynamic changes in soluble interleukin-2 receptor levels during treatment of Graves' disease. Horm Res 35:8?12","journal-title":"Horm Res"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF03347915","volume":"14","author":"S Mariotti","year":"1991","unstructured":"Mariotti S, Caturegli P, Barbesino G, Prete GFD, Chiovato L, Pinchera A (1991) Circulating soluble interleukin-2 receptor concentration is increased in both immunogenic and nonimmunogenic hyperthyroidism. J Endocrinol Invest 14:777?781","journal-title":"J Endocrinol Invest"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2265.1990.tb00496.x","volume":"33","author":"CC Chow","year":"1990","unstructured":"Chow CC, Lai KN, Leung JCK, Chan JCN, Cockram CS (1990) Serum soluble interleukin-2 receptor in hyperthyroid Graves' disease and effect of carbimazole therapy. Clin Endocrinol 33:317?321","journal-title":"Clin Endocrinol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0896-8411(91)90185-F","volume":"4","author":"CZ Balazs","year":"1991","unstructured":"Balazs CZ, Farid NR (1991) Soluble interleukin-2 receptor in sera of patients with Graves' diseases. J Autoimmun 4:681?688","journal-title":"J Autoimmun"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0753-3322(91)90086-9","volume":"45","author":"CS Balazs","year":"1991","unstructured":"Balazs CS (1991) Increased level of soluble interleukin-2 receptor in sera of patients with Graves' disease. Biomed Pharmacother 45:311?314","journal-title":"Biomed Pharmacother"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1530\/acta.0.1250253","volume":"125","author":"K Nakanishi","year":"1991","unstructured":"Nakanishi K, Taniguchi Y, Ohta Y (1991) Increased soluble interleukin-2 receptor levels in autoimmune thyroid disease. Acta Endocrinol 125:253?258","journal-title":"Acta Endocrinol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08916939008998426","volume":"8","author":"R Wilson","year":"1990","unstructured":"Wilson R, Mckillop JH, Buchanan LM, Bradley H, Smith WE, Thomson JA (1990) The effect of carbimazole therapy on interleukin-2, interleukin-2 receptors and free radicals. Autoimmunity 8:3?7","journal-title":"Autoimmunity"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jcem-73-4-771","volume":"73","author":"E Koukkou","year":"1991","unstructured":"Koukkou E, Panayiotidis P, Alevizou-Terzaki V, Thalassions N (1991) High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: Correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism. J Clin Endocrinol Metab 73:771?776","journal-title":"J Clin Endocrinol Metab"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF00227352","volume":"70","author":"M Hufner","year":"1992","unstructured":"Hufner M, Wermann M, Gru\u00dfendorf M, Heilig B (1992) Is soluble CD25 antigen (interleukin-2 receptor) a useful parameter for differential diagnosis of thyrotoxicosis? Clin Invest 70:122?124","journal-title":"Clin Invest"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1530\/acta.0.1200602","volume":"120","author":"KN Lai","year":"1989","unstructured":"Lai KN, Leung JCK, Chow CC, Cockram CS (1989) T lymphocyte activation in euthyroid Graves' ophthalmopathy: soluble interleukin-2 receptor release, cellular interleukin-2 receptor expression and interleukin-2 production. Acta Endocrinol 120:602?609","journal-title":"Acta Endocrinol"},{"key":"CR17","first-page":"61","volume":"151","author":"Y Hirooka","year":"1989","unstructured":"Hirooka Y, Ohtake K, Yuasa K, Ishikawa A, Kayama M, Okamoto H, Nakata K, Nogimori T, Mitsuma T (1989) Decreased Interleukin-2 production in Graves' disease (in Japanese). Igaku no Ayumi 151:61?62","journal-title":"Igaku no Ayumi"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2249.1992.tb06462.x","volume":"88","author":"MF Prummel","year":"1992","unstructured":"Prummel MF, Wiersinga WM, Van Der Gaag R, Mourits MP, Koornneef L (1992) Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy. Clin Exp Immunol 88:405?409","journal-title":"Clin Exp Immunol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2177\/jsci.15.20","volume":"15","author":"Y Ohno","year":"1992","unstructured":"Ohno Y, Ito K, Kishitani Y, Ikami H, Imamura M, Aoki N (1992) Abnormalities of in vitro production of interleukin-1 and interleukin-2 in Graves' disease (in Japanese). Nihon Rinsho Men\u00e9ki Gakkai Kaishi (Jpn J Clin Immun) 15:20?28","journal-title":"Nihon Rinsho Men\u00e9ki Gakkai Kaishi (Jpn J Clin Immun)"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jcem-65-1-17","volume":"65","author":"N Ishikawa","year":"1987","unstructured":"Ishikawa N, Eguchi K, Otsubo T, Ueki Y, Fukuda T, Tezuka H, Matsunaga M, Kawabe Y, Shimomura C, Izumi M, Ban Y, Ito K, Nagataki S (1987) Reduction in the suppressor-inducer T cell and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease. J Clin Endocrinol Metab 65:17?23","journal-title":"J Clin Endocrinol Metab"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/jcem-69-5-939","volume":"69","author":"Y Ueki","year":"1989","unstructured":"Ueki Y, Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Tezuka H, Nakao H, Kawakami A, Migita K, Ishikawa N, Ito K, Nagataki S (1989) Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease. J Clin Endocrinol Metab 69:939?945","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00309386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00309386\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00309386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T16:12:25Z","timestamp":1682784745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00309386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["BF00309386"],"URL":"https:\/\/doi.org\/10.1007\/bf00309386","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}